Coya Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Coya Therapeutics, Inc. (COYA) reported Basic Shares Outstanding (Weighted Average) of 23.46 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 23.46M shares, a 40.25% increase year-over-year.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 22.64M shares, a 35.43% increase year-over-year.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 16.74M shares, a 2.36% increase year-over-year.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 16.73M shares, a 9.93% increase year-over-year.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 16.73M shares, a 9.79% increase from fiscal 2024.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 15.24M shares, a 49.93% increase from fiscal 2023.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 10.16M shares, a 292.40% increase from fiscal 2022.
- Coya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 2.59M shares, a 0.01% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 23.46M shares 10-Q · filed 2026-08-11 | 23.05M shares 10-Q · filed 2026-08-11 | 20.95M shares derived: average of 3 quarters · filed 2026-08-11 | 19.89M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 22.64M shares 10-Q · filed 2026-05-12 | 19.69M shares derived: average of 2 quarters · filed 2026-05-12 | 18.71M shares derived: average of 3 quarters · filed 2026-05-12 | 18.21M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 16.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 16.74M shares derived: average of 2 quarters · filed 2026-03-16 | 16.73M shares derived: average of 3 quarters · filed 2026-08-11 | 16.73M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 16.73M shares 10-Q · filed 2025-11-12 | 16.73M shares derived: average of 2 quarters · filed 2026-08-11 | 16.73M shares 10-Q · filed 2025-11-12 | 16.63M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 16.72M shares 10-Q · filed 2026-08-11 | 16.72M shares 10-Q · filed 2026-08-11 | 16.60M shares derived: average of 3 quarters · filed 2026-08-11 | 16.26M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 16.72M shares 10-Q · filed 2026-05-12 | 16.54M shares derived: average of 2 quarters · filed 2026-05-12 | 16.10M shares derived: average of 3 quarters · filed 2026-05-12 | 15.80M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 16.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 15.79M shares derived: average of 2 quarters · filed 2026-03-16 | 15.50M shares derived: average of 3 quarters · filed 2026-03-16 | 15.24M shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 15.22M shares 10-Q · filed 2025-11-12 | 15.07M shares derived: average of 2 quarters · filed 2025-11-12 | 14.87M shares 10-Q · filed 2025-11-12 | 13.91M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 14.92M shares 10-Q · filed 2025-08-12 | 14.69M shares 10-Q · filed 2025-08-12 | 13.47M shares derived: average of 3 quarters · filed 2025-08-12 | 12.59M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 14.46M shares 10-Q · filed 2025-05-13 | 12.75M shares derived: average of 2 quarters · filed 2025-05-13 | 11.81M shares derived: average of 3 quarters · filed 2025-05-13 | 11.35M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 11.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 10.49M shares derived: average of 2 quarters · filed 2025-03-18 | 10.31M shares derived: average of 3 quarters · filed 2025-03-18 | 10.16M shares 10-K · filed 2025-03-18 |
| 2023-09-30 | 9.95M shares 10-Q · filed 2024-11-06 | 9.95M shares derived: average of 2 quarters · filed 2024-11-06 | 9.87M shares 10-Q · filed 2024-11-06 | 8.05M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 9.95M shares 10-Q · filed 2024-08-12 | 9.84M shares 10-Q · filed 2024-08-12 | 7.42M shares derived: average of 3 quarters · filed 2024-08-12 | 6.21M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 9.72M shares 10-Q · filed 2024-05-09 | 6.16M shares derived: average of 2 quarters · filed 2024-05-09 | 4.97M shares derived: average of 3 quarters · filed 2024-05-09 | 4.37M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 2.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 2.59M shares derived: average of 2 quarters · filed 2024-03-19 | 2.59M shares derived: average of 3 quarters · filed 2024-03-19 | 2.59M shares 10-K · filed 2024-03-19 |
| 2022-09-30 | 2.59M shares 10-Q · filed 2023-11-08 | 2.59M shares derived: average of 2 quarters · filed 2023-11-08 | 2.59M shares 10-Q · filed 2023-11-08 | |
| 2022-06-30 | 2.59M shares 10-Q · filed 2023-08-08 | 2.59M shares 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 2.59M shares 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 2.59M shares 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |